ANNUAL ERADICATION RATE OF BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION: A 15-YEAR PROSPECTIVE STUDY AT A TERTIARY HOSPITAL IN KOREA

被引:0
|
作者
Kim, Nayoung
Yoon, Kichul
Lee, Dong Ho
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1379
引用
收藏
页码:S571 / S571
页数:1
相关论文
共 50 条
  • [1] Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea
    Yoon, Kichul
    Kim, Nayoung
    Lee, Jung Won
    Yoon, Hyuk
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    HELICOBACTER, 2020, 25 (03)
  • [2] Second-Line Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A 12-Year Study of Annual Eradication Rates
    Shin, Kiwon
    Cho, Min-Jae
    Oh, Jung-Hwan
    Lim, Chul-Hyun
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [3] Second line bismuth-containing quadruple therapy for Helicobacter pylori eradication in Korea
    Cho, M.
    Hwang, H.
    Kim, Y.
    Lim, C.
    Oh, J.
    HELICOBACTER, 2019, 24
  • [4] Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
    Lee, Byoung Hwan
    Kim, Nayoung
    Hwang, Tae Jun
    Lee, Sang Hyub
    Park, Young Soo
    Hwang, Jin-Hyeok
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Lee, Dong Hoo
    Jung, Hyun Chae
    Song, In Sung
    HELICOBACTER, 2010, 15 (01) : 38 - 45
  • [5] Eradication rate of Bismuth-containing quadruple therapy as a second-line treatment for H-pylori infection
    Jee, S. R.
    Lee, S. H.
    Jung, E. U.
    Ok, K. S.
    Kim, J. H.
    Choi, J. S.
    Lee, Y. J.
    Seol, S. Y.
    HELICOBACTER, 2010, 15 (04) : 345 - 345
  • [6] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Sung Eun Kim
    Moo In Park
    Seun Ja Park
    Won Moon
    Jae Hyun Kim
    Kyoungwon Jung
    Hae Koo Kim
    Young Dal Lee
    World Journal of Gastroenterology, 2017, (06) : 1059 - 1066
  • [7] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
  • [8] Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea
    Cheon, Jae Hee
    Kim, Nayoung
    Lee, Dong Ho
    Kim, Jung Mogg
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (05) : 515 - 519
  • [9] META-ANALYSIS OF LEVOFLOXACIN-CONTAINING TRIPLE THERAPY VERSUS BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT IN THE ERADICATION OF HELICOBACTER PYLORI
    Marin, A. C.
    McNicholl, A. G.
    Gisbert, J. P.
    HELICOBACTER, 2011, 16 : 132 - 132
  • [10] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
    Lee, M.
    Lee, B.
    Kim, G.
    Park, E.
    Jeon, H.
    Song, G.
    HELICOBACTER, 2017, 22